These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 7449327

  • 1. [Treatment of chronic ischemic cardiopathy with a combination of pyridinolcarbamate and clofibrate].
    Guerrera G, Melina D.
    Clin Ter; 1980 Mar 15; 92(5):533-47. PubMed ID: 7449327
    [No Abstract] [Full Text] [Related]

  • 2. [Therapeutic results with combination of pyridinolcarbamate and clofibrate in atherosclerotic patients].
    Valiensi M, Riboli E, Lombardi M.
    Minerva Cardioangiol; 1976 Feb 15; 24(2):148-54. PubMed ID: 1256654
    [No Abstract] [Full Text] [Related]

  • 3. [The pyridinolcarbamate-clofibrate combination in the treatment of vascular diseases in diabetics].
    Parodi FA, Caputo G.
    Clin Ter; 1976 Dec 31; 79(6):571-81. PubMed ID: 1009761
    [No Abstract] [Full Text] [Related]

  • 4. [Influence of pyridinolcarbamate on platelet aggregation in diabetic subjects with ischemic cardiopathy].
    Citarrella P, Abbadessa V, Pecorella M, Cajozzo A.
    Boll Soc Ital Cardiol; 1977 Dec 31; 22(7):1036-41. PubMed ID: 618239
    [No Abstract] [Full Text] [Related]

  • 5. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
    Pola P.
    Minerva Cardioangiol; 1975 Apr 31; 23(4):261-9. PubMed ID: 1095958
    [No Abstract] [Full Text] [Related]

  • 6. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
    Pola P.
    J Pharm Sci; 1975 Jan 31; 64(1):261-9. PubMed ID: 1094102
    [No Abstract] [Full Text] [Related]

  • 7. [Use of clofibrate and pyridinol carbamate singly or in combination in the antiarteriosclerotic therapy].
    Meciani L, Boeri S, Ricci G.
    Minerva Cardioangiol; 1974 Jan 31; 22(7-8):512-42. PubMed ID: 4606052
    [No Abstract] [Full Text] [Related]

  • 8. [Results of a 5-year study of the action of clofibrate in the treatment of ischemic cardiopathy].
    Dewar HA.
    Minerva Med; 1971 Sep 26; 62(72):3456-7. PubMed ID: 5097216
    [No Abstract] [Full Text] [Related]

  • 9. [Treatment of arteriosclerotic peripheral chronic obliterating arteriopathies (A.P.C.O.) of the lower extremities with a new pharmacologic combination].
    Bagliani A, Borri P, Parravicini R.
    Minerva Cardioangiol; 1975 Nov 26; 23(11):701-10. PubMed ID: 1223674
    [No Abstract] [Full Text] [Related]

  • 10. [Pyridinolcarbamate treatment of ischemic heart disease].
    Kuz'ko NV.
    Vrach Delo; 1976 Jan 26; (1):27-30. PubMed ID: 1246850
    [No Abstract] [Full Text] [Related]

  • 11. [Critical review of clinical experimentation with clofibrate in coronary disease].
    Azzena D, Astengo F.
    Minerva Cardioangiol; 1973 Jan 26; 21(7):497-502. PubMed ID: 4756344
    [No Abstract] [Full Text] [Related]

  • 12. [Study of pharmacodynamics and pharmacokinetics of clofibrate for the purpose of selection of optimal course of treatment of ischemic heart disease].
    Kukes VG, Senik EA, Gneushev ET, Utlinskaia MG, Nasonov AS.
    Ter Arkh; 1979 Jan 26; 51(12):57-61. PubMed ID: 538720
    [No Abstract] [Full Text] [Related]

  • 13. [Primary prevention of ischemic cardiopathy with clofibrate].
    Balaguer Vintro I.
    Rev Esp Cardiol; 1979 Jan 26; 32(3):209-11. PubMed ID: 493624
    [No Abstract] [Full Text] [Related]

  • 14. [The clofibrate-dipyridamole combination in the prevention and therapy of arteriosclerotic vascular disease and its complications].
    Cucinotta D, Ferretti PG, Daccò L, Mazzera F.
    G Clin Med; 1977 Jan 26; 58(11-12):475-86. PubMed ID: 608558
    [No Abstract] [Full Text] [Related]

  • 15. [Clofibrate and coronary disease].
    Nikkilä E.
    Duodecim; 1972 Jan 26; 88(10):684-7. PubMed ID: 5068883
    [No Abstract] [Full Text] [Related]

  • 16. [Pharmacological action on the thrombocyte link in hemostasis in the treatment of ischemic heart disease].
    Komarov FI, Liusov VA, Bokarev IN.
    Kardiologiia; 1978 Mar 26; 18(3):12-8. PubMed ID: 347133
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of hyperlipidemia in patients with ischemic heart disease].
    Haviar V, Kusá O, Riecanský I, Luknárová O.
    Vnitr Lek; 1972 Jun 26; 18(6):586-91. PubMed ID: 5044447
    [No Abstract] [Full Text] [Related]

  • 18. [Effect of various preparations on hyperuricemia in coronary arteriosclerosis].
    Anisimov VE, Goliakov VN, Semavin IE.
    Ter Arkh; 1977 Jun 26; 49(9):134-6. PubMed ID: 73228
    [No Abstract] [Full Text] [Related]

  • 19. [Determination of chlorphenoxyisobutyrate in the blood of chronic ischemic heart disease patients under prolonged miscleron treatment].
    Gneushev ET, Utlinskaia MG, Shitov NN, Senik EA.
    Farmakol Toksikol; 1980 Jun 26; 43(3):335-7. PubMed ID: 7449973
    [Abstract] [Full Text] [Related]

  • 20. [Miscleron in the treatment of patients with atherosclerosis of the coronary and cerebal vessels].
    Sivkov II, Kukes VG, Kirichenko LL, Fedosova NS, Ishmaeva KA.
    Sov Med; 1971 Sep 26; 34(9):54-7. PubMed ID: 5121295
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.